Scoring systems improve timing of cell transplant for MDS patients

06/27/2013 | MDSBeacon.com

The use of prognosis scoring systems to time donor stem cell transplantation may extend the lives of patients treated for myelodysplastic syndromes, according to a study in the American Journal of Hematology. Researchers in Italy found that delayed transplantation may be better for patients whose early illness is considered very low- or low-risk by the World Health Organization classification-based Prognostic Scoring System and low-risk by the International Prognostic Scoring System.

View Full Article in:

MDSBeacon.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR